What patients say about medical research

IRB Ethics and Human Research

Volumn 20, Issue 4, 1998, Pages 1-7

  Sugarman, Jeremy ^a   Kass, Nancy E ^b   Goodman, Steven N ^c   Perentesis, Patricia ^d   Fernandes, Praveen ^e   Faden, Ruth R ^b,f  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CL McIntosh and Associates   (United States)

^e IL   (United States)

^f GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVISORY COMMITTEE; ADVISORY COMMITTEE ON HUMAN RADIATION EXPERIMENTS; AFRICAN AMERICAN; ALTRUISM; ARTICLE; ATTITUDE; BIOMEDICAL AND BEHAVIORAL RESEARCH; COGNITION; COMPREHENSION; DECISION MAKING; DIAGNOSIS; EMPIRICAL APPROACH; EPIDEMIOLOGY; EVALUATION; FEE; HEART DISEASE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; MOTIVATION; NEOPLASM; NOMENCLATURE; PATIENT; PATIENT PARTICIPATION; PERSUASIVE COMMUNICATION; PHYSICIAN; POLICY; RESEARCH; RESEARCH SUBJECT; RISK; RISK ASSESSMENT; SOCIOECONOMICS; TRUST; UNITED STATES;

ADVISORY COMMITTEE ON HUMAN RADIATION EXPERIMENTS; BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

ADVISORY COMMITTEES; AFRICAN AMERICANS; ALTRUISM; ATTITUDE; BIOMEDICAL RESEARCH; COERCION; COGNITION; COMMUNICATION; COMPREHENSION; CONSENT FORMS; DATA COLLECTION; DECISION MAKING; DIAGNOSIS; EPIDEMIOLOGY; EVALUATION STUDIES; FEES AND CHARGES; HEART DISEASES; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; MOTIVATION; NEOPLASMS; NONTHERAPEUTIC HUMAN EXPERIMENTATION; PATIENT PARTICIPATION; PATIENTS; PHYSICIANS; PUBLIC POLICY; RESEARCH; RESEARCH SUBJECTS; RISK; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; TERMINOLOGY; THERAPEUTIC HUMAN EXPERIMENTATION; TRUST; UNITED STATES;

EID: 84865921861     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: 10.2307/3564262     Document Type: Article

References (21)

1. Executive Order 12891, signed 15 January 1994.
2. SAS Institute: SAS software and JMP software. Research Triangle Park, North Carolina.
3. Cytel Corporation: Egret software. Seattle, Washington.
4. Logistical difficulties and time constraints precluded making requests for 4 patient-subjects. The total number of forms requested is greater than the number of subjects, since some respondents were enrolled in more than 1 project.
5. Jones JH: Bad Blood: The Tuskegee Syphilis Experiment. New York Free Press, 1981.
6. Thomas CR, Pinto HA, Roach M, Vaughn CB: Participation in clinical trials: Is it state-of-the-art treatment for African Americans and other people of color? Journal of the National Medical Association 1994;86:177-82.
7. Swanson GM, Ward AJ: Recruiting minorities into clinical trials: Toward a participant-friendly system. Journal of the National Cancer Institute 1995;87:1747-59.
8. Harris Y, Gorelick PB, Samuels P, Bempong I: Why African Americans may not be participating in clinical trials. Journal of the National Medical Association 1996;88:630-4.
9. Roberson NL: Clinical trial participation: Viewpoints from racial/ethnic groups. Cancer 1994;74:2687-91.
10. Schafer A: The ethics of the randomized clinical trial. New England Journal of Medicine 1982; 307:719-24.
11. Appelbaum PS, Roth LH, Lidz CW: The therapeutic misconception: Informed consent in psychiatric research. International Journal of Law & Psychiatry 1982; 5:319-29.
12. Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W: False hopes and best data: Consent to research and the therapeutic misconception. Hastings Center Report 1987; 17(2):20-4.
13. Millon-Underwood S, Sanders E, Davis M: Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nursing 1993; 16:25-33.
14. Mattson M, Curb JD, McArdle R, and the Aspirin Myocardial Infarction Study (AMIS) and Beta-Blocker Heart Attack Trial (BHAT) Research Groups: Participation in a clinical trial: The patients' point of view. Controlled Clinical Trials 1985; 6:156-67.
15. Cassileth BR, Lusk EJ, Miller DS, Hurwitz S: Attitudes toward clinical trials among patients and the public. JAMA 1982:248:968-70.
16. Advisory Committee on Human Radiation Experiments: Final Report of the Advisory Committee on Human Radiation Experiments (Stock #: 061-000-00-848-9). Washington, D.C.: U.S. Government Printing Office, 1995.
17. Gray BH: An assessment of institutional review committees in human experimentation. Medical Care 1975; 13:318-28.
18. Gray BH, Cooke RA, Tannebaum AS: Research involving human subjects. Science 1978; 201:1094-1101.
19. Ockene IS, Miner J, Shannon TA, Gore JM, Weiner BH, et al.: The consent process in the Thrombolysis in Myocardial Infarction (TIMI-phase I) trial. Clinical Research 1991; 39:13-7.
20. Riecken HW, Ravich R: Informed consent to biomedical research in Veterans Administration hospitals. JAMA 1982; 248:344-8.
21. Rodenhuis S, Van Den Heuvel WJA, Annyas AA, Koops HS, Sleijfer DT, et al.: Patient motivation and informed consent in a phase I study of an anticancer agent. European Journal of Cancer and Clinical Oncology 1984; 20:457-62.